Shanghai Shyndec Pharmaceutical Co (SHSE:600420) ROCE % : 9.86% (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Shyndec Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 9.86%.

Shanghai Shyndec Pharmaceutical Co ROCE % Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shyndec Pharmaceutical Co ROCE % Chart

Shanghai Shyndec Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.00

10.00

8.44

7.89

7.45

Shanghai Shyndec Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															8.26	4.65	13.56	15.52	9.86

Shanghai Shyndec Pharmaceutical Co ROCE % Calculation

Shanghai Shyndec Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1154.443	/	( ( (19630.346 - 4195.506)	+	(19352.282 - 3779.675) )	/ 2 )
	=	1154.443	/	( (15434.84	+	15572.607)	/ 2 )
	=	1154.443	/	15503.7235
	=	7.45 %

Shanghai Shyndec Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	1517.712	/	( ( (19969.316 - 4635.427)	+	(20066.164 - 4618.226) )	/ 2 )
	=	1517.712	/	( ( 15333.889	+	15447.938 )	/ 2 )
	=	1517.712	/	15390.9135
	=	9.86 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Shanghai Shyndec Pharmaceutical Co (SHSE:600420) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Shyndec Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Shyndec Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Shyndec Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No.1320 Beijinxi Road, Shanghai, CHN, 200040

Website

http://www.shyndec.com

Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.

Executives

Li Hao	senior management
Ni Feng	Director
Li Xian Lin	senior management
Hao Chao Feng	senior management
Lian Wan Yong	Director
Han Yan Lin	Director
Yang Wen Ming	Supervisors
Feng Ming	Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines